reports
Moody's Ratings upgrades Wanaque, NJ to Aa3
Moody's Ratings (Moody's) has upgraded Wanaque, NJ's issuer and general obligation unlimited tax (GOULT) ratings to Aa3 from A1. As of year end 2022, the borough had $21.5 million of debt outstanding. The upgrade to Aa3 reflects the borough's healthy financial position supplemented by a stable loc...
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nas...
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that on May 1, 2024, the Compensation Committee of Praxis’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 7,800 shares of its common stock an...
Summary Notice of Pendency and Proposed Settlement of Shareholder Deri...
Summary Notice of Pendency and Proposed Settlement of Shareholder Derivative Actions CUPERTINO, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Apple Inc. has released the following notice: A Federal Court authorized this Notice. This is not a solicitation from a lawyer. TO: ALL PERSONS OR ENTITIES WHO OR WHICH HELD SHARES OF APPLE INC. (“APPLE” OR THE “COMPANY”) COMMON STOCK AS OF THE CLOSE OF TRADING ON APRIL 29, 2024. THIS NOTICE RELATES TO THE PENDENCY AND PROPOSED SETTLEMENT OF SHAREHOLDER DERIVATIVE LITIGATION. PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. IF YOU ARE A CURRENT ...
Moody's Ratings affirms the EFSF's ratings at Aaa, maintains stable ou...
Moody's Ratings ("Moody's") has today affirmed the Aaa long-term issuer rating of the European Financial Stability Facility (EFSF). The EFSF's backed senior unsecured bond and backed senior unsecured MTN programme ratings were also affirmed at Aaa and (P)Aaa, respectively, while the backed other sho...
Moody's Ratings assigns Aaa to Iowa FA's Single Family Mtg. Bds. 2024 ...
Moody's Ratings (Moody's) has assigned Aaa ratings to Iowa Finance Authority's proposed $80 million Single Family Mortgage Bonds 2024 Series C (Non-AMT) (Social Bonds) (Mortgage-Backed Securities Program) and $69 million Single Family Mortgage Bonds 2024 Series D (Taxable) (Mortgage-Backed Securitie...
Moody's Ratings affirms the ESM's ratings at Aaa, maintains stable out...
Moody's Ratings ("Moody's") has today affirmed the Aaa long-term issuer rating of the European Stability Mechanism (ESM). The ESM's senior unsecured bond and senior unsecured MTN programme ratings were also affirmed at Aaa and (P)Aaa, respectively, while the short-term issuer and commercial paper pr...
Moody's Ratings affirms City of Conroe, TX's issuer, GOLT, and subordi...
Moody's Ratings (Moody's) has affirmed the City of Conroe, TX's Aa1 issuer and general obligation limited tax (GOLT) ratings and Conroe Industrial Development Corporation, TX's (CIDC) A2 combination third lien hotel revenue and subordinate contract revenue bonds (hereafter known as "subordinate lien...
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing ...
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that on May 1, 2024, an authorized sub-committee of the Board of Directors of Mersana granted an inducement award, consisting of a restricted stock unit (RSU) award to acquire 35,100 shares of its common stock, to one ...
CNH announces voting results of 2024 Annual General Meeting and publis...
CNH announces voting results of 2024 Annual General Meeting and publishes 2023 Sustainability Report Basildon, May 3, 2024 CNH Industrial N.V. (NYSE: CNHI) today held its annual general meeting of shareholders. Shareholders re-appointed the Company’s director nominees, including Suzanne Heywood and Scott W. Wine as executive directors1, and Elizabeth Bastoni, Howard W. Buffett, Richard J. Kramer, Karen Linehan, Alessandro Nasi, Vagn Sørensen and Åsa Tamsons as non-executive directors. Shareholders also approved a dividend of $0.47 per common share (equivalent to a total distribution of...
Cornerstone Funds Announce Continuing Monthly Distributions
Cornerstone Funds Announce Continuing Monthly Distributions NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Cornerstone Strategic Value Fund, Inc. (NYSE American: CLM) (CUSIP: 21924B302) and Cornerstone Total Return Fund, Inc. (NYSE American: CRF) (CUSIP: 21924U300), (individually the “Fund” or, collectively, the “Funds”), each a closed-end management investment company, announced that in keeping with each Fund’s previously adopted monthly distribution policy, each Fund is declaring the following distributions. Record Date Payable DatePer Share CLMJuly 15, 2024July 31,...
Fate Therapeutics Announces Presentation of FT522 Preclinical Data for...
Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting Off-the-shelf, CD19-targeted CAR NK Cell Product Candidate Drives Rapid and Deep Depletion of SLE Donor CD19+ B cells ADR Technology Incorporated into FT522 Induces Functional Persistence and Eliminates Alloreactive Host Immune Cells in SLE Donor PBMCs SAN DIEGO, May 03, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripote...
Territorial Bancorp Inc. Announces First Quarter 2024 Results
Territorial Bancorp Inc. Announces First Quarter 2024 Results The Company’s tier one leverage and risk-based capital ratios were 11.58% and 28.84%, respectively, and the Company is considered to be “well-capitalized” at March 31, 2024.Ratio of non-performing assets to total assets of 0.10% at March 31, 2024.Strong liquidity position with $90 million in cash balances and access to liquidity totaling $901.70 million as of March 31, 2024. HONOLULU, Hawaii, May 03, 2024 (GLOBE NEWSWIRE) -- Territorial Bancorp Inc. (NASDAQ: TBNK) (the “Company”), headquartered in Honolulu, Hawaii, the holdi...
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Pe...
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to June 3, 2024 Filed by Vision Sensing Acquisition Corp.Pursuant to Rule 425 under the Securities Act of 1933and deemed filed pursuant to Rule 14a-12under the Securities Exchange Act of 1934Subject Company: Vision Sensing Acquisition Corp.Commission File No. 001-40983 NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special purpose acquisition company, announced today that on May 2, 2024, its spo...
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing...
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) NEW YORK and WALTHAM, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (“Dianthus”), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced that it granted equity awards on May 1, 2024, to two newly-hired, non-executive employees. The inducement grants were approved by the Company's independent Compensation Committee and were made as material inducements to acceptance of...
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Ru...
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO and SAN DIEGO, May 03, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on May 1, 2024 (the “Grant Date”), ORIC granted a total of 14,500 non-qualified stock options and 2,300 restricted stock units to two new non-executive employees who began their employment with ORIC in April 2024. These inducement grants were granted pursuant t...
Jayud Global Logistics Receives Nasdaq Notification of Non-Compliance ...
Jayud Global Logistics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5550(b)(1) SHENZHEN, China, May 03, 2024 (GLOBE NEWSWIRE) -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solution provider based in Shenzhen, specializing in cross-border logistics, today announced that on May 1, 2024, it received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is no longer in compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market. ...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards of Restricted Stock Units representing a total of 55,650 shares of the Company’s common stock (RSUs) to thirteen new non-executive employees. In accordance with NASDAQ Listing Rule 5635(c)(4), these awa...
Brookfield Property Partners Declares Quarterly Dividends on Listed Pr...
Brookfield Property Partners Declares Quarterly Dividends on Listed Preferred Units All dollar references are in U.S. dollars, unless noted otherwise. BROOKFIELD NEWS, May 03, 2024 (GLOBE NEWSWIRE) -- Brookfield Property Partners (“BPY” or the "Partnership") announced today that the Board of Directors has declared quarterly distributions on the Partnership’s Class A Nasdaq-listed BPYPP, BPYPO, BPYPN and BPYPM (TSX: BPYP.PR.A) preferred units of $0.40625 per unit, $0.3984375 per unit, $0.359375 per unit and $0.390625 per unit, respectively, payable on June 28, 2024, to holders of record a...
Moody's Ratings affirms Cox Enterprises' and Cox Communications' Baa2 ...
Moody's Ratings (Moody's) affirmed Cox Enterprises, Inc.'s (CEI) Baa2 long-term issuer rating, Baa2 senior unsecured notes rating, Baa2 revolving credit facility rating and Prime-2 commercial paper rating. Moody's also affirmed Cox Communications, Inc.'s (CCI) Baa2 senior unsecured notes ratings and...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.